Coloplast AS 

M$1,875.47
275
+M$0+0% Tuesday 14:52

統計

當日最高
1,875.47
當日最低
1,875.47
52週高點
1,875.47
52週低點
1,845.58
成交量
0
平均成交量
2,473
市值
388.91B
本益比
-
股息殖利率
3.51%
股息
65.88

即將到來

股息

3.51%股息殖利率
Dec 25
M$51.24
May 25
M$14.65
Dec 24
M$48.68
May 24
M$12.14
Dec 23
M$40.04
10年成長
2.39%
5年成長
1.38%
3年成長
7.67%
1年成長
不適用

財報

12May預期
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
下一步
11.44
13.5
15.55
17.61
預期EPS
16.540453324834917
實際EPS
不適用

財務

13.04%利潤率
有盈利
2020
2021
2022
2023
2024
2025
161.84B營收
21.11B淨利

其他人也在關注

此清單是根據在 Stock Events 上追蹤 0QBON.MX 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more...
執行長
Mr. Lars Soren Rasmussen Ph.D.
員工
16983
國家
DK
ISIN
DK0060448595

上市

0 Comments

分享你的想法

FAQ

Coloplast AS 今天的股價是多少?
0QBON.MX 目前價格為 M$1,875.47 MXN,過去 24 小時上漲了 +0%。在圖表上更密切關注 Coloplast AS 股價表現。
Coloplast AS 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Coloplast AS 的股票以代號 0QBON.MX 進行交易。
Coloplast AS 的市值是多少?
今天 Coloplast AS 的市值為 388.91B
Coloplast AS 下一次財報日期是什麼時候?
Coloplast AS 將於 May 12, 2026 公布下一次財報。
Coloplast AS 上一季度的財報如何?
0QBON.MX 上一季度的財報為每股 17.11 MXN,預估為 16.53 MXN,帶來 +3.46% 的驚喜。下一季度的預估財報為每股 不適用 MXN。
Coloplast AS 去年的營收是多少?
Coloplast AS 去年的營收為 161.84BMXN。
Coloplast AS 去年的淨利是多少?
0QBON.MX 去年的淨收益為 21.11BMXN。
Coloplast AS 會發放股息嗎?
是的,0QBON.MX 的股息每 半年一次 發放一次。每股最新股息為 51.24 MXN。截至今日,股息殖利率(FWD)% 為 3.51%。
Coloplast AS 有多少名員工?
截至 April 06, 2026,公司共有 16,983 名員工。
Coloplast AS 位於哪個產業?
Coloplast AS從事於Health Care產業。
Coloplast AS 何時完成拆股?
Coloplast AS 上次拆股發生於 December 19, 2012,比例為 5:1。
Coloplast AS 的總部在哪裡?
Coloplast AS 的總部位於 DK 的 Humlebæk。